John Newman
Stock Analyst at Canaccord Genuity
(0)
# 4319
Out of 5,218 analysts
112
Total ratings
43.10%
Success rate
-8.73%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BioNTech | Maintains: Buy | 171 171 | 120.2 | 42.26% | 7 | Nov 18, 2024 | |
Seres Therapeutics | Maintains: Buy | 10 10 | 0.88 | 1036.36% | 9 | Nov 14, 2024 | |
Atara Biotherapeutic... | Maintains: Strong Buy | 13 21 | 10.36 | 102.7% | 3 | Nov 13, 2024 | |
Ocuphire Pharma | Maintains: Buy | 18 10 | n/a | n/a | 3 | Oct 23, 2024 | |
Delcath Systems | Maintains: Buy | 21 21 | 12.09 | 73.7% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 85 115 | 83.86 | 37.13% | 8 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 8 | 0.97 | 724.74% | 6 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 14 | 1.89 | 640.74% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 67 67 | 42.8 | 56.54% | 2 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 38 43 | 18.67 | 130.32% | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 1152 1152 | 730.7 | 57.66% | 14 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 6 | 0.19 | 3057.89% | 1 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 11 | 3.27 | 236.39% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 25 | n/a | n/a | 5 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | 0.81 | 517.28% | 2 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 9 | n/a | n/a | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 40 72 | n/a | n/a | 4 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 44 | 39.09 | 12.56% | 8 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1720 400 | 6.36 | 6189.31% | 3 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 100 140 | n/a | n/a | 1 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 65 56 | n/a | n/a | 7 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 380 100 | 2.28 | 4285.96% | 2 | Apr 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Oct 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 210 220 | 5.34 | 4019.85% | 3 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 54 0 | n/a | n/a | 3 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 300 | n/a | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 38 | 15.59 | 143.75% | 2 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 30 | n/a | n/a | 2 | Sep 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 27 | 4.94 | 446.56% | 2 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Speculative Buy | n/a | n/a | n/a | 1 | Sep 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 18 | n/a | n/a | 1 | Aug 30, 2016 |